This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yazlovitskaya, E. M. Articles by Hallahan, D. E. Search for Related Content PubMed PubMed Citation Articles by Yazlovitskaya, E. M. Articles by Hallahan, D. E.

Lithium Treatment Prevents Neurocognitive Deficit Resulting from Cranial Irradiation

¹ Department of Radiation Oncology, ² Vanderbilt-Ingram Cancer Center, ³ Department of Pathology, and ⁴ Vanderbilt Microarray Shared Resource, Vanderbilt University School of Medicine, Nashville, Tennessee

Requests for reprints: Dennis E. Hallahan, Department of Radiation Oncology, Vanderbilt University, 1301 22nd Avenue South, B-902 The Vanderbilt Clinic, Nashville, TN 37232-5671. Phone: 615-343-9244; Fax: 615-343-3075; E-mail: Dennis.Hallahan{at}vanderbilt.edu.

Curative cancer treatment regimens often require cranial irradiation, resulting in lifelong neurocognitive deficiency in cancer survivors. This deficiency is in part related to radiation-induced apoptosis and decreased neurogenesis in the subgranular zone of the hippocampus. We show that lithium treatment protects irradiated hippocampal neurons from apoptosis and improves cognitive performance of irradiated mice. The molecular mechanism of this effect is mediated through multiple pathways, including Akt/glycogen synthase kinase-3ß (GSK-3ß) and Bcl-2/Bax. Lithium treatment of the cultured mouse hippocampal neurons HT-22 induced activation of Akt (1.5-fold), inhibition of GSK-3ß (2.2-fold), and an increase in Bcl-2 protein expression (2-fold). These effects were sustained when cells were treated with lithium in combination with ionizing radiation. In addition, this combined treatment led to decreased expression (40%) of the apoptotic protein Bax. The additional genes regulated by lithium were identified by microarray, such as decorin and Birc1f. In summary, we propose lithium treatment as a novel therapy for prevention of deleterious neurocognitive consequences of cranial irradiation. (Cancer Res 2006; 66(23): 11179-86)

This article has been cited by other articles:

				S. Rosi, M. Andres-Mach, K. M. Fishman, W. Levy, R. A. Ferguson, and J. R. Fike Cranial Irradiation Alters the Behaviorally Induced Immediate-Early Gene Arc (Activity-Regulated Cytoskeleton-Associated Protein) Cancer Res., December 1, 2008; 68(23): 9763 - 9770. [Abstract] [Full Text] [PDF]

				J. Dietrich, M. Monje, J. Wefel, and C. Meyers Clinical Patterns and Biological Correlates of Cognitive Dysfunction Associated with Cancer Therapy Oncologist, December 1, 2008; 13(12): 1285 - 1295. [Abstract] [Full Text] [PDF]

				D. K. Thotala, D. E. Hallahan, and E. M. Yazlovitskaya Inhibition of Glycogen Synthase Kinase 3{beta} Attenuates Neurocognitive Dysfunction Resulting from Cranial Irradiation Cancer Res., July 15, 2008; 68(14): 5859 - 5868. [Abstract] [Full Text] [PDF]